AR

Abdu Razak

Active Director Designated Partner DIN 10399023
DIN 10399023 First appointment Nov 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdu Razak

Data last updated:

Abdu Razak is a Designated Partner at Vallanchira Hospital Llp (since 2023). The company operates in Healthcare.

DIN 10399023
Primary Designation Designated Partner
Industry Healthcare
First Appointment 21 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Nov 20232023Active

Board colleagues of Abdu Razak

Directorship timeline

Open interactive timeline →
Vallanchira Hospital Llp
Premium access

Shareholding and investment profile for Abdu Razak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdu Razak

Abdu Razak currently holds 1 directorship: Vallanchira Hospital Llp (Designated Partner, since 21 Nov 2023).

Abdu Razak was first appointed on 21 Nov 2023 as Designated Partner at Vallanchira Hospital Llp.

The current boards of Abdu Razak's companies include Abdul Jaleel Vallanchira (Vallanchira Hospital Llp), Abdussalam Vallanchira (Vallanchira Hospital Llp), Valanchira House Abdul Raheem (Vallanchira Hospital Llp), Vallanchira Abdul Gafoor (Vallanchira Hospital Llp), Vallanchira Abdulla Hassan (Vallanchira Hospital Llp), Vallanchira Ahammed Sageer (Vallanchira Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available